StockData
Jazz Pharmaceuticals plc logo

Jazz Pharmaceuticals plc (JAZZ) income statement

JAZZNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 7/30122% above fair value
$247.77+7.06 (+2.93%)

Close on Nov 18, 2026Market cap $16.08BP/E 80.7Yield –

Jazz Pharmaceuticals plc income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
–
Operating margin
9.0%
Net margin
4.4%
Return on equity, FY2025
-8.5%

Financial strength

Current ratio
1.82
Debt to equity
1.33
Debt to assets
46.4%
Cash to current liabilities
80.4%

Valuation

P/E ratio
80.7
Price to sales
3.41
Price to book
3.84
Dividend yield
–

See a number that looks wrong?